Free, publicly available container solution supported by and built on AWS allows users to create custom on-demand container images to support scientific collaboration and discoveries NEW YORK—Seqera, the leading software provider for complex data analysis in the life sciences space, today announced the launch of Seqera Containers, a no-cost, streamlined bioinformatics container solution, during their […]
NEW YORK, NEW YORK, USA — Basepair Inc., a pioneering provider of bioinformatics solutions, today announced that it is working with Amazon Web Services (AWS) to help accelerate life science organizations’ ability to harness the full potential of genomic data analysis. By integrating AWS HealthOmics capabilities into its cutting-edge Software-as-a-Service (SaaS) platform, Basepair is revolutionizing […]
Cambridge, United Kingdom – Congenica, a UK-based digital health company specialising in innovative software and solutions for genomic data analysis and interpretation, is pleased to announce its selection for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology. The European Union Horizon 2020 co-funded project, ‘INtegrated and STANDardized NGS workflows […]
The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, […]
The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use […]
As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is approved for diagnostic use Regulatory framework ensures greater patient protection, transparency of information, and traceability of data Over 4 million NGS patient test cases for oncology and hereditary diseases worldwide processed with QIAGEN Clinical […]
Optibrium partners with FMC Corporation to transform agrochemical discovery CAMBRIDGE, UK and CAMBRIDGE – Optibrium, a leading developer of software and AI solutions for drug discovery, has signed a license agreement for its AI-powered discovery platform, Cerella™, with FMC Corporation (FMC), a global leader in crop protection. Under the agreement, FMC will implement Cerella to […]
We are pleased to announce that Golden Helix has received CE mark approval for its genetic analysis platform VarSeq Suite. This significant regulatory milestone paves the way for the expansion of our advanced genetic analytics products to the European market, ensuring compliance with the European Union’s health, safety, and environmental protection standards. Receiving the CE […]
QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data New software advances precision medicine by enabling smaller and decentralized labs to adopt NGS testing with efficiency, consistency and confidence Combination of QCI Secondary Analysis and QCI Interpret provide a secure and compliant environment for […]
Genomenon Making Variant Data on the PIK3CD and PIK3R1 Genes Available to Genetic Testing Labs Across the World Genomenon, a genomic intelligence company, has partnered with Pharming Group in an effort to make variant data on the PIK3CD and PIK3R1 genes available to genetic testing labs, as well as clinicians and researchers, worldwide. This data […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
